A.M. Vitals: New Weight-Loss Drug, and Treatment Prospect for Alzheimer’s

by Blog Burger on July 19, 2012

Here’s what’s making health news this morning:

FDA Grants Approval to Diet Pill From Vivus (WSJ): Approval of Vivus’s weight-loss drug Qsymia marks the second approval of a new weight-loss drug in less than a month; the drugs, which require a doctor’s prescription, won’t be available until later this year.

Immune Drug Shows Promise for Alzheimer’s (WSJ): A tiny but promising new study suggests that a medicine already on the market, intravenous immunoglobulin therapy, or IVIG, may offer benefits to Alzheimer’s patients—a result likely to spur interest in using the therapy off-label even though it is in limited supply.

Health Blog

Comments on this entry are closed.

Previous post:

Next post: